ViewRay Inc. (VRAYQ)
OTCMKTS: VRAYQ · Delayed Price · USD
0.00
0.00 (0.00%)
May 3, 2024, 4:00 PM EDT - Market closed

ViewRay Revenue

ViewRay had revenue of $105.86M in the twelve months ending March 31, 2023, with 44.09% growth year-over-year. Revenue in the quarter ending March 31, 2023 was $22.53M with 19.38% year-over-year growth. In the year 2022, ViewRay had annual revenue of $102.21M with 45.76% growth.

Revenue (ttm)
$105.86M
Revenue Growth
+44.09%
P/S Ratio
0.00
Revenue / Employee
$358,861
Employees
295
Market Cap
18.34K USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2022102.21M32.09M45.76%
Dec 31, 202170.12M13.10M22.98%
Dec 31, 202057.02M-30.77M-35.05%
Dec 31, 201987.78M6.82M8.42%
Dec 31, 201880.96M46.92M137.83%
Dec 31, 201734.04M11.81M53.09%
Dec 31, 201622.24M11.85M114.02%
Dec 31, 201510.39M3.99M62.37%
Dec 31, 20146.40M3.24M102.56%
Dec 31, 20133.16M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 371.62B
Johnson & Johnson 81.80B
Merck & Co. 60.12B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings